Roivant Sciences Ltd.
SEC CIK 1635088 · EDGAR
BoughtSold
Most active insiders at IMVT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Roivant Sciences Ltd. | Dir, 10% | $350.00M | — |
| 2 | Fromkin Andrew J. | Dir | — | $7.96M |
| 3 | Stout Jay S | CTO | — | $2.27M |
| 4 | Gloria Melanie | COO | — | $1.60M |
| 5 | Girao Tiago | CFO | — | $1.41M |
| 6 | Van Tuyl Christopher | CLO | — | $1.31M |
| 7 | Venker Eric | CEO, Dir | — | $461.8K |
| 8 | Pande Atul | Dir | — | $424.6K |
| 9 | Hughes Douglas J. | Dir | — | $348.7K |
| 10 | Geffner Michael | Chief Medical Off | — | $70.1K |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-12 | 2025-12-12 | IMVT | Immunovant, Inc. | Roivant Sciences Ltd. | Dir, 10% | P - Purchase | $21.00 | +16.67M | 113.32M | +17% | +$350.00M | |
| 2025-01-15 | 2025-01-13 | IMVT | Immunovant, Inc. | Roivant Sciences Ltd. | Dir, 10% | P - Purchase | $20.00 | +16.85M | 96.65M | +21% | +$336.90M | |
| 2023-10-04 | 2023-10-02 | IMVT | Immunovant, Inc. | Roivant Sciences Ltd. | Dir, 10% | P - Purchase | $38.00 | +1.53M | 79.81M | +2% | +$58.00M | |
| 2023-10-04 | 2023-10-02 | IMVT | Immunovant, Inc. | Roivant Sciences Ltd. | Dir, 10% | A - Grant | $38.00 | +4.47M | 78.28M | +6% | +$170.00M | |
| 2022-10-07 | 2022-10-06 | IMVT | Immunovant, Inc. | Roivant Sciences Ltd. | 10% | P - Purchase | $6.00 | +416.7K | 73.81M | +0.6% | +$2.50M | |
| D | 2021-10-20 | 2021-10-18 | ABUS | Arbutus Biopharma Corp | Roivant Sciences Ltd. | 10% | C - Cnv Deriv | — | +22.83M | 38.85M | +143% | — |
| 2021-08-02 | 2021-08-02 | IMVT | Immunovant, Inc. | Roivant Sciences Ltd. | 10% | J - Other | — | +17.02M | 73.39M | +30% | — |
Purchase Sale Sale after option exercise All abbreviations